American Heart Journal
Volume 157, Issue 3 , Pages 423-427 , March 2009

The rationale and design of the FORωARD Trial: A randomized, double-blind, placebo-controlled, independent study to test the efficacy of n-3 PUFA for the maintenance of normal sinus rhythm in patients with previous atrial fibrillation

  • Alejandro Macchia

      Affiliations

    • Fundación GESICA (Grupo de Estudio en Investigación Clínica en Argentina), Buenos Aires, Argentina
    • Corresponding Author InformationReprint requests: Alejandro Macchia, Fundación GESICA, Av. Rivadavia 2358, 1 “4” – C1034ACP Buenos Aires, Argentina.
  • ,
  • Sergio Varini

      Affiliations

    • Fundación GESICA (Grupo de Estudio en Investigación Clínica en Argentina), Buenos Aires, Argentina
  • ,
  • Hugo Grancelli

      Affiliations

    • Fundación GESICA (Grupo de Estudio en Investigación Clínica en Argentina), Buenos Aires, Argentina
  • ,
  • Daniel Nul

      Affiliations

    • Fundación GESICA (Grupo de Estudio en Investigación Clínica en Argentina), Buenos Aires, Argentina
  • ,
  • Nicolas Laffaye

      Affiliations

    • Fundación GESICA (Grupo de Estudio en Investigación Clínica en Argentina), Buenos Aires, Argentina
  • ,
  • Daniel Ferrante

      Affiliations

    • Fundación GESICA (Grupo de Estudio en Investigación Clínica en Argentina), Buenos Aires, Argentina
  • ,
  • Gianni Tognoni

      Affiliations

    • Consorzio Mario Negri Sud, Santa Maria Imbaro, Chieti, Italy
  • ,
  • Hernan C. Doval

      Affiliations

    • Fundación GESICA (Grupo de Estudio en Investigación Clínica en Argentina), Buenos Aires, Argentina
  • ,
  • on behalf of the FORWARD investigators

Received 16 September 2008 ,Accepted 31 October 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 ClinicalTrial.gov identifier: NCT00597220.

PII: S0002-8703(08)00975-7

doi: 10.1016/j.ahj.2008.10.027

American Heart Journal
Volume 157, Issue 3 , Pages 423-427 , March 2009